Technical Articles

anti-TSLP monoclonal antibody

The TSLP Turning Point from Atopic Dermatitis to Asthma: How an Epithelial Cytokine Reshapes Type 2 Inflammation Targeting

2026-10-08

Once viewed as a downstream effector, TSLP is now an upstream driver target of type 2 inflammation. This article traces its narrative from epithelial alarmin to anti-TSLP therapy milestones and translational research.

View details

Immunity/Inflamma
TSLP
type 2 inflammation
atopic dermatitis
asthma
anti-TSLP monoclonal antibody
epithelial cytokine
translational research
UA016092

Total 1

Go to